Oral Ulcers Affect Quality Of Life In Behçets Disease
Objectives: This study aimed to investigate the quality of life in Turkish patients with Behçets Disease. Methods: Sixty nine patients with Behcets Disease (F/M: 33/36, mean age:32.1±7.8 years), 17 patients with recurrent aphtous stomatitis (F/M: 9/8, 32.1±9.3 yrs) and 70 Turkish healthy controls (F/M: 57/57, 34.2±12.3 yrs) were included in the study. Both clinical manifestations and oral health of patients with Behcets Disease were evaluated in Behcets Disease Clinics of the Marmara and Cerrahpasa Medical Schools in Istanbul. Quality of life was evaluated by oral health impact profile-14 (OHIP-14), oral health related quality of life (OHQoL) and short form-36 (SF-36) questionnaires. Forward-backwards translations were carried out and reliabilities of them were assessed. Internal reliabilities of questionnaires were found to be high: Cronbachs alpha= 0.93 for OHIP, 0.92 for OHRQoL and 0.90 for SF-36 in the study. Results: The mean scores of OHQoL and subscales of SF-36 as physical functioning, role, physical, bodily pain, general health and vitality were significantly higher in healthy controls than Behcets Disease patients (p<0.05), although no significant difference was observed between patients with Behcets Disease and recurrent apthous stomatitis (p>0.05). In addition, the mean score of OHIP-14 was significantly worse in patients with Behcets Disease than healthy controls (p=0.000) and in patients with active oral ulcers compared to patients without ulcers in Behcets Disease (p=0.005). Similarly, scores of OHQoL and vitality of patients having active oral ulcers were significantly lower than patients without ulcers (p=0.001 and p=0.025, respectively). Conclusions: The quality of life is negatively affected in patients with Behcets Disease. Since oral ulcers are related with impaired oral quality of life and vitality, they should be eliminated to improve the quality of life in Behcets Disease patients. Key word: Oral ulceration, quality of life, OHIP, OHQoL, SF-36, Behçets disease.